Opthea has discontinued development of sozinibercept in wet age-related macular degeneration, according to a press release.

Opthea (OPT) announced updates on its Phase 3 clinical program, including the termination of COAST and accelerated topline results from its ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

ShORe Phase 3 topline results accelerated; trial did not meet primary endpoint of mean change in BCVA from baseline to week 52 Opthea and DFA Investors agreed to terminate both COAST and ShORe trials ...

Wheel of Fortune' Season 42 is just around the corner! Currently, the fans of the beloved game show are busy watching the reruns featuring some of the most iconic moments. One of the most pivotal ...

Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A ...

Opthea’s eye disease drug has failed its second phase 3 trial in a week, leaving the Australian biotech to discard the entire ...

It’s normal for people to confront memories of their own childhood as they embark on parenthood. As you sort through these feelings, find a professional who can help you deal with them. Everyone in ...

Naomi Elkins said she believed she was eradicating evil and bringing about the coming of the Messiah by killing her two daughters.

Some drugs are known as nephrotoxic, which means that their effects can cause damage to the kidneys. Drugs such as certain ...

Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement ...

The BRAIN Initiative — the full name is Brain Research Through Advancing Innovative Neurotechnologies — has been talked about ...